Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person K2 (vIL-6) mRNA is both a delayed/early transcript (Arias et...

Class:IdSummation:9992068
_displayNameK2 (vIL-6) mRNA is both a delayed/early transcript (Arias et...
_timestamp2026-06-06 09:04:15
created[InstanceEdit:9992079] Stephan, Ralf, 2026-06-06
textK2 (vIL-6) mRNA is both a delayed/early transcript (Arias et al., 2014) and released on virion entry into cytosol, as part of mRNAs trapped during virion budding. It is therefore also expressed immediately (Bechtel et al., 2005). It is translated into nascent K2 protein of 204 amino acids and a predicted molecular weight of 23.5 kDa (Chandriani & Ganem, 2010).
(summation)[BlackBoxEvent:9991268] K2 mRNA is translated into nascent K2 [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by K2 (vIL-6) mRNA is both a delayed/early transcript (Arias et... (9992068)